Medical AI Alliance
← Company Index
Pharma & CDMOKOSPI 293480458 approvals65 trials

Hana Pharm. Co., Ltd.

Official website

Manufactures narcotic analgesics, anesthetics, and 380+ insurance-listed prescription drugs.

As of 2026-10-10, Hana Pharm. Co., Ltd. has 458 Korean MFDS drug approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1978 and listed on KOSPI in 2018, Hana Pharm is a prescription drug manufacturer. With strengths in narcotic analgesics and anesthetics, it produces over 380 health-insurance-listed drugs spanning circulatory, analgesic, digestive, neurology, and dermatology products, operating three plants in Hwaseong, Gyeonggi and an R&D center in Pangyo. It in-licensed remimazolam from Germany's Paion, obtaining Korean MFDS marketing approval on January 7, 2021 and now selling it there while pursuing approvals in six Southeast Asian countries, and it signed an option agreement with Canada's Bold Therapeutics for Korean market rights to the targeted anticancer drug BOLD-100, which is now in domestic clinical trials.

Products & technology

  • RemimazolamAnesthetic/sedative
  • Finished pharmaceuticals (380+ listed drugs)Circulatory, analgesic, digestive, neurology, and dermatology drugs

Regulatory approvals

data.go.kr

458 Korean MFDS drug approvals · 1970–2026

  • MFDS drugOcodone CR Tab. 40mg2026-07-28
    Drug · Prescription · Approval202602182
  • MFDS drugHana Fentanyl Citrate Inj.2026-07-02
    Drug · Prescription · Approval202601936
  • MFDS drugHanafen Tab.2026-06-30
    Drug · Prescription · Approval202601862
  • MFDS drugOneclean Tab.2026-05-03
    Drug · Prescription · Approval202601317
  • MFDS drugVonowon Tab. 10mg2026-04-23
    Drug · Prescription · Approval202601196
  • MFDS drugVonowon Tab. 20mg2026-04-23
    Drug · Prescription · Approval202601197
  • MFDS drugDonet M Tab. 10/20mg2026-03-05
    Drug · Prescription · Approval202600665
  • MFDS drugTelmidipine Pro Tab. 80/5/12.5mg2025-12-16
    Drug · Prescription · Approval202503292
  • MFDS drugTelmidipine Pro Tab. 40/5/12.5mg2025-12-16
    Drug · Prescription · Approval202503293
  • MFDS drugTelmidipine Pro Tab. 80/5/25mg2025-12-15
    Drug · Prescription · Approval202503277
  • MFDS drugMega-act Tab.2025-11-04
    Drug · OTC · Notification202502846
  • MFDS drugMyone Eye Drops 0.125%2025-10-29
    Drug · Prescription · Approval202502791
Show 68 more
  • MFDS drugLipatin Duo Tab. 2/160mg2025-08-29
    Drug · Prescription · Approval202502272
  • MFDS drugHana Ramset Vial Inj. 0.3mg2025-05-29
    Drug · Prescription · Approval202501338
  • MFDS drugJardice Duo XR Tab. 25/1000mg2025-05-21
    Drug · Prescription · Approval202501246
  • MFDS drugJardice Duo XR Tab. 10/1000mg2025-05-21
    Drug · Prescription · Approval202501247
  • MFDS drugHyalone Alpha Inj.(BDDE crosslinked Hyaluronic acid)(Prefilled)2025-05-13
    Drug · Prescription · Approval202501160
  • MFDS drugLansatone Duo Tab. 15/600mg2025-03-14
    Drug · Prescription · Approval202500563
  • MFDS drugTelmidipine R Tab. 40/5/5mg2025-03-07
    Drug · Prescription · Approval202500518
  • MFDS drugTelmidipine R Tab. 80/5/5mg2025-03-05
    Drug · Prescription · Approval202500492
  • MFDS drugHana GinkoM Tab. 240mg2024-12-11
    Drug · OTC · Notification202402920
  • MFDS drugZolpione Tab. 10mg2024-12-10
    Drug · Prescription · Approval202402908
  • MFDS drugParamet Duo Tab. 20/700mg2024-08-30
    Drug · Prescription · Approval202402104
  • MFDS drugParamet Duo Tab. 10/700mg2024-08-30
    Drug · Prescription · Approval202402105
  • MFDS drugSugaone Prefilled Inj.2024-07-29
    Drug · Prescription · Approval202401819
  • MFDS drugSerline Tab. 10mg2024-06-24
    Drug · Prescription · Approval202401524
  • MFDS drugMegaone Plus Tab.2024-02-21
    Drug · OTC · Notification202400366
  • MFDS drugSerline Tab. 30mg2023-12-21
    Drug · Prescription · Approval202303396
  • MFDS drugHana GinkoM-duo Cap.2023-11-20
    Drug · OTC · Notification202303166
  • MFDS drugMontero Plus Tab.2023-10-30
    Drug · Prescription · Approval202303015
  • MFDS drugJardice Duo Tab. 12.5/1000mg2023-09-20
    Drug · Prescription · Approval202302786
  • MFDS drugJardice Duo Tab. 12.5/500mg2023-09-20
    Drug · Prescription · Approval202302787
  • MFDS drugJardice Duo Tab. 12.5/850mg2023-09-20
    Drug · Prescription · Approval202302788
  • MFDS drugOne fresh Eye Drops 1%2023-08-11
    Drug · OTC · Notification202302427
  • MFDS drugAlpraone Tab. 0.25mg2023-02-28
    Drug · Prescription · Approval202300713
  • MFDS drugAlpraone Tab. 0.5mg2023-02-28
    Drug · Prescription · Approval202300714
  • MFDS drugLumasate Prefilled Inj.2023-01-13
    Drug · Prescription · Approval202300248
  • MFDS drugLansatone Duo Tab. 30/600mg2023-01-09
    Drug · Prescription · Approval202300169
  • MFDS drugLight-Slim Tab. 60mg2023-01-06
    Drug · Prescription · Approval202300158
  • MFDS drugFimaone-S Tab. 30/2.5mg2022-12-27
    Drug · Prescription · Approval202204663
  • MFDS drugFimaone-S Tab. 60/2.5mg2022-12-27
    Drug · Prescription · Approval202204664
  • MFDS drugSitaoneplus Tab. 50/850mg2022-12-21
    Drug · Prescription · Approval202204585
  • MFDS drugSitaoneplus Tab. 50/500mg2022-12-21
    Drug · Prescription · Approval202204586
  • MFDS drugSitaoneplus Tab. 50/1000mg2022-12-21
    Drug · Prescription · Approval202204587
  • MFDS drugJK ODF. 20mg2022-12-06
    Drug · Prescription · Approval202204394
  • MFDS drugJK ODF. 10mg2022-12-06
    Drug · Prescription · Approval202204395
  • MFDS drugFoglin Tab.2022-12-02
    Drug · Prescription · Approval202204329
  • MFDS drugLight-Slim Tab. 120mg2022-11-18
    Drug · Prescription · Approval202204143
  • MFDS drugEzosta Tab. 3mgRevoked2022-08-31
    Drug · Prescription · Approval202203438
  • MFDS drugEzosta Tab. 2mgRevoked2022-08-31
    Drug · Prescription · Approval202203439
  • MFDS drugEzosta Tab. 1mgRevoked2022-08-31
    Drug · Prescription · Approval202203440
  • MFDS drugHanaperamivir Premix Inj.2022-07-27
    Drug · Prescription · Approval202203103
  • MFDS drugHanasugaone Inj.2022-07-27
    Drug · Prescription · Approval202203118
  • MFDS drugByfavo Inj. 20mg2022-07-04
    Drug · Prescription · Approval202202754
  • MFDS drugTerium M SR Tab.2022-07-01
    Drug · Prescription · Approval202202710
  • MFDS drugTerium M SR Tab.2022-07-01
    Drug · Prescription · Approval202202711
  • MFDS drugTerium M SR Tab.2022-07-01
    Drug · Prescription · Approval202202712
  • MFDS drugPolbit Cap. 2mg2022-06-07
    Drug · Prescription · Approval202202358
  • MFDS drugWonbufen Premix Inj.2022-06-07
    Drug · Prescription · Notification202202363
  • MFDS drugFoglin Tab.2022-05-30
    Drug · Prescription · Approval202202271
  • MFDS drugSitaoneplus XR Tab. 50/500mg2022-05-11
    Drug · Prescription · Approval202201958
  • MFDS drugSitaoneplus XR Tab. 50/1000mg2022-05-11
    Drug · Prescription · Approval202201959
  • MFDS drugSitaoneplus XR Tab. 100/100mg2022-05-11
    Drug · Prescription · Approval202201960
  • MFDS drugJardice Duo Tab. 5/1000mg2022-04-04
    Drug · Prescription · Approval202201351
  • MFDS drugJardice Duo Tab. 5/850mg2022-04-04
    Drug · Prescription · Approval202201352
  • MFDS drugJardice Duo Tab. 5/500mg2022-04-04
    Drug · Prescription · Approval202201353
  • MFDS drugOnepecia Tab. 1mg2022-01-18
    Drug · Prescription · Approval202200293
  • MFDS drugDexmedine Premix Inj.2022-01-07
    Drug · Prescription · Approval202200137
  • MFDS drugSitaone Duo Tab. 10/100mg2022-01-04
    Drug · Prescription · Approval202200049
  • MFDS drugByfavo Inj. 20mg2021-08-30
    Drug · Prescription · Approval202106240
  • MFDS drugMegaone Tab.2021-08-24
    Drug · OTC · Notification202106143
  • MFDS drugLecough CR Tab.2021-06-30
    Drug · Prescription · Approval202104977
  • MFDS drugNexpa Duo Tab.20/800mg2021-06-18
    Drug · Prescription · Approval202104744
  • MFDS drugEtoxia Tab. 30mg2021-04-27
    Drug · Prescription · Approval202103440
  • MFDS drugByfavo Inj. 50mg2021-04-27
    Drug · Prescription · Approval202103430
  • MFDS drugDonet Tab. 23mg2021-04-05
    Drug · Prescription · Approval202102916
  • MFDS drugTelium Tab. 20mg2021-04-01
    Drug · Prescription · Approval202102861
  • MFDS drugRoxaone Tab. 15mg2021-03-22
    Drug · Prescription · Approval202102479
  • MFDS drugRoxaone Tab. 10mg2021-03-22
    Drug · Prescription · Approval202102480
  • MFDS drugJardice Tab. 25mg2021-03-05
    Drug · Prescription · Approval202102089

Showing the 80 most recent of 458 records.

Clinical trials

data.go.kr

65 MFDS clinical trial authorisations · 2012–2026 (Bioequivalence 57 · Phase 1 6 · Phase 2 1 · Phase 3 1)

  • Bioequivalence로스토린정10/2.5밀리그램(에제티미브,로수바스타틴칼슘)2026-04-01

    1 trial site

  • Bioequivalence리파토린정4/10밀리그램2025-10-02

    2 trial sites

  • Phase 1HN010012025-07-22

    1 trial site

  • Bioequivalence하나펜정(펠루비프로펜(미분화))2025-06-23

    2 trial sites

  • Bioequivalence오코돈플러스서방정10/5밀리그램2025-03-17

    2 trial sites

  • Bioequivalence리파토린정4/10밀리그램2025-02-14

    2 trial sites

  • Phase 1HN340122024-05-20

    2 trial sites

  • Phase 1HN340152024-05-20

    2 trial sites

  • Phase 1HN340122024-05-17

    2 trial sites

  • Phase 1HN340152024-05-17

    2 trial sites

  • Bioequivalence오코돈플러스서방정10/5밀리그램2024-04-03

    2 trial sites

  • Bioequivalence하나펜타닐박칼정400마이크로그램(펜타닐시트르산염)2023-04-05

    2 trial sites

Show 53 more
  • Bioequivalence레코푸정(레보드로프로피진)2022-12-05

    2 trial sites

  • Bioequivalence하나클러캡슐(세파클러수화물)2022-11-01

    2 trial sites

  • Bioequivalence하나클러캡슐(세파클러수화물)2022-03-02

    2 trial sites

  • Bioequivalence코바라탄정80/12.5mg2022-02-14

    2 trial sites

  • Bioequivalence발라디핀정10/160밀리그램2021-12-09

    2 trial sites

  • Bioequivalence레스탐정(레바미피드)2021-12-09

    2 trial sites

  • Bioequivalence사포란정100밀리그램(사르포그렐레이트염산염)2021-06-14

    2 trial sites

  • Bioequivalence텔미디핀정80/5밀리그램2021-06-03

    2 trial sites

  • Bioequivalence칸데라정16밀리그램(칸데사르탄실렉세틸)2021-04-05

    2 trial sites

  • Bioequivalence테리아정20밀리그램(테네리글립틴브롬화수소산염수화물)2021-01-27

    2 trial sites

  • Bioequivalence알프라원정0.5밀리그램(알프라졸람)2021-01-15

    2 trial sites

  • Phase 2HNP-20062021-01-15

    1 trial site

  • Bioequivalence쎌비트캡슐200밀리그램(세레콕시브)2020-12-29

    1 trial site

  • Bioequivalence졸피원정10밀리그램(졸피뎀타르타르산염)2020-12-18

    2 trial sites

  • Bioequivalence람세트오디정0.1밀리그램(라모세트론염산염)2020-11-25

    1 trial site

  • Bioequivalence원픽사반정5밀리그램(아픽사반)2020-10-13

    2 trial sites

  • Bioequivalence리파틴정2밀리그램(피타바스타틴칼슘)2020-08-11

    2 trial sites

  • Bioequivalence세비원정5/40밀리그램2020-07-24

    2 trial sites

  • Bioequivalence실로탄정100밀리그램(실로스타졸)2020-07-13

    2 trial sites

  • Bioequivalence도네트정10밀리그램(도네페질염산염)2020-05-08

    2 trial sites

  • Bioequivalence아리토린정10/20밀리그램2020-03-02

    2 trial sites

  • Bioequivalence아리토린정10/40밀리그램2020-01-30

    2 trial sites

  • Bioequivalence오코돈플러스서방정10/5밀리그램2019-11-05

    2 trial sites

  • Bioequivalence오코돈플러스서방정10/5밀리그램2019-11-04

    2 trial sites

  • Bioequivalence로스토린정10/20밀리그램2019-09-10

    2 trial sites

  • Bioequivalence세비원정10/40밀리그램2019-03-06

    2 trial sites

  • Phase 1HNP-20062019-02-12

    2 trial sites

  • Bioequivalence넥스파정 40mg2018-11-30

    2 trial sites

  • Phase 3HNP-20012017-10-31

    12 trial sites

  • Bioequivalence프레진정(가칭)2017-05-30

    2 trial sites

  • Bioequivalence하나알티옥트산트로메타민정(가칭)2017-02-03

    2 trial sites

  • Bioequivalence타스린정(가칭)2016-06-29
  • Bioequivalence오스톨정(리세드론산나트륨)2016-02-15

    2 trial sites

  • Bioequivalence코바라탄정160/12.5mg2015-11-10

    2 trial sites

  • Bioequivalence레스탐정(레바미피드)2015-10-23

    2 trial sites

  • Bioequivalence트라미펜정2015-09-24
  • Bioequivalence듀오디핀정2015-08-28
  • Bioequivalence트루윈캡슐4밀리그램(실로도신)2015-08-28

    2 trial sites

  • Bioequivalence텔미디핀정80/5밀리그램2015-08-20

    2 trial sites

  • Bioequivalence파라메트정10밀리그램(라베프라졸나트륨)2015-06-02

    2 trial sites

  • Bioequivalence치오티드에이취알정600mg(티옥트산)2014-09-18
  • Bioequivalence레페라정(레트로졸)2014-09-18
  • Bioequivalence오코돈정2014-02-05

    2 trial sites

  • Bioequivalence로수탄정10밀리그램(로수바스타틴)2014-01-16
  • Bioequivalence티아론정(티아넵틴나트륨)2014-01-06
  • Bioequivalence텔미라정80mg(텔미사르탄)2013-12-10

    2 trial sites

  • Bioequivalence발라디핀정 10/160mg2013-12-10

    2 trial sites

  • Bioequivalence칸데라정16밀리그람(칸데사르탄실렉세틸)2013-10-21
  • Bioequivalence이베타정300밀리그램2013-10-14

    2 trial sites

  • Bioequivalence토맥스정100mg(토피라메이트)2013-09-30

    2 trial sites

  • Bioequivalence에페라정(에페리손염산염)2013-07-19
  • Bioequivalence부스원정5밀리그램(부스피론염산염)2013-01-22
  • Bioequivalence코바라탄정160/12.5mg2012-08-20

    2 trial sites

R&D and key agreements

Source: DART corporate disclosure

BOLD-100 · 표적항암 · 국내임상 진행중 · Conducting domestic clinical trials after securing Korean market rights via an option agreement with Bold Therapeutics

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 37 more patents

AI reads

MAA server logs · IP-verified
80
Times AI engines pulled Hana Pharm. Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

5
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

75
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

12
live 1
Last 7 days
58
live 3
Last 30 days
80
live 5
All time
  • OpenAIChatGPT-Userlive5
  • OpenAIOAI-SearchBot69
  • AnthropicClaudeBot2
  • PerplexityPerplexityBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 9, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Hana Pharm. Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition